Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Telormedix S.A.
DescriptionSecond generation toll-like receptor 7 (TLR7) small molecule
Molecular Target Toll-like receptor 7 (TLR7)
Mechanism of Action 
Therapeutic ModalityAdjuvant
Latest Stage of DevelopmentPreclinical
Standard IndicationAdjuvant
Indication DetailsVaccine adjuvant for malaria
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today